[
    [
        {
            "time": "2021-04-19",
            "original_text": "【权益变动】药明康德(02359-HK)获贝莱德增持35.34万股",
            "features": {
                "keywords": [
                    "药明康德",
                    "贝莱德",
                    "增持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【权益变动】药明康德(02359-HK)获贝莱德增持35.34万股",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-19",
            "original_text": "生产人员年薪酬50万，是同行的几倍，药明康德这么豪真的好吗？",
            "features": {
                "keywords": [
                    "药明康德",
                    "生产人员",
                    "薪资"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "生产人员年薪酬50万，是同行的几倍，药明康德这么豪真的好吗？",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-19",
            "original_text": "北向资金爆买逾160亿元，新能源汽车概念股获大幅加仓",
            "features": {
                "keywords": [
                    "北向资金",
                    "新能源汽车",
                    "加仓"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金爆买逾160亿元，新能源汽车概念股获大幅加仓",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-04-19",
            "original_text": "上交所、中证指数公司发布中证红利质量指数等3条指数",
            "features": {
                "keywords": [
                    "上交所",
                    "中证指数",
                    "红利质量指数"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上交所、中证指数公司发布中证红利质量指数等3条指数",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-04-19",
            "original_text": "粤开证券--医药行业周报：网售处方药全面放开，第五批带量采购箭在弦上【行业研究】",
            "features": {
                "keywords": [
                    "网售处方药",
                    "带量采购",
                    "医药行业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "粤开证券--医药行业周报：网售处方药全面放开，第五批带量采购箭在弦上【行业研究】",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-19",
            "original_text": "东吴证券--医药生物行业：第五批带量采购对恒瑞医药影响有限，仍坚定看好【行业研究】",
            "features": {
                "keywords": [
                    "带量采购",
                    "恒瑞医药",
                    "医药生物"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东吴证券--医药生物行业：第五批带量采购对恒瑞医药影响有限，仍坚定看好【行业研究】",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-04-19",
            "original_text": "Wind医药：每日行业动态（2021-04-19）",
            "features": {
                "keywords": [
                    "Wind医药",
                    "行业动态"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "Wind医药：每日行业动态（2021-04-19）",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        }
    ]
]